Related Experiment Video
Updated: Mar 21, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Fatal Pediatric Metformin-Associated Lactic Acidosis: When Severity Goes Unnoticed
Inês Noites1,2, Marta Figueiredo1,3, Zakhar Shchomak1
1Pediatric Intensive Care Unit, Pediatrics Department, Unidade Local de Saúde de Santa Maria, Lisbon, PRT.
Abstract:
Metformin poisoning is rare in the pediatric population but can lead to life-threatening metformin-associated lactic acidosis (MALA) and multiorgan failure, particularly when diagnosis or intervention is delayed. We report the case of a 16-year-old girl who intentionally ingested 34 g of her prescribed metformin following an emotional trigger. She presented to the emergency department one hour after ingestion, hemodynamically stable with unremarkable laboratory findings; however, venous blood gas analysis was not performed at admission. Within 15 hours, she developed severe metabolic acidosis consistent with MALA, acute kidney injury, and progressive hemodynamic instability requiring resuscitative efforts, mechanical ventilation, and vasopressor support. Continuous renal replacement therapy was initiated in the pediatric intensive care unit, but no meaningful clinical improvement was observed. Despite aggressive management, she developed cerebral edema with cerebellar tonsillar herniation and was declared brain dead 46 hours after ingestion. This case reinforces the importance of early recognition and prompt multidisciplinary management of patients at high risk for MALA, given the potential for rapid progression to severe and refractory metabolic acidosis, even in individuals who appear clinically stable at presentation. It also highlights hypoglycemia as a rare but critical manifestation of severe metformin toxicity.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: Biguanides and Glitazones